A detailed history of Trexquant Investment LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Trexquant Investment LP holds 310,702 shares of BMRN stock, worth $20.7 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
310,702
Previous 130,501 138.08%
Holding current value
$20.7 Million
Previous $10.7 Million 103.27%
% of portfolio
0.29%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$69.02 - $93.84 $12.4 Million - $16.9 Million
180,201 Added 138.08%
310,702 $21.8 Million
Q2 2024

Aug 13, 2024

BUY
$74.43 - $92.22 $8.48 Million - $10.5 Million
113,896 Added 685.91%
130,501 $10.7 Million
Q1 2024

May 14, 2024

BUY
$83.81 - $99.0 $1.39 Million - $1.64 Million
16,605 New
16,605 $1.45 Million
Q3 2023

Nov 13, 2023

SELL
$85.07 - $94.48 $5.12 Million - $5.69 Million
-60,175 Reduced 49.41%
61,605 $5.45 Million
Q2 2023

Aug 11, 2023

BUY
$86.68 - $100.3 $10.6 Million - $12.2 Million
121,780 New
121,780 $10.6 Million
Q2 2022

Aug 11, 2022

SELL
$71.48 - $86.85 $2.6 Million - $3.16 Million
-36,379 Reduced 91.1%
3,555 $295,000
Q1 2022

May 13, 2022

BUY
$74.28 - $92.69 $2.97 Million - $3.7 Million
39,934 New
39,934 $3.08 Million
Q4 2021

Feb 14, 2022

SELL
$71.72 - $91.47 $2.58 Million - $3.29 Million
-35,967 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $1.94 Million - $2.22 Million
25,943 Added 258.81%
35,967 $2.78 Million
Q2 2021

Aug 12, 2021

SELL
$75.51 - $84.79 $278,933 - $313,214
-3,694 Reduced 26.93%
10,024 $836,000
Q1 2021

May 13, 2021

BUY
$74.73 - $90.69 $1.03 Million - $1.24 Million
13,718 New
13,718 $1.04 Million
Q4 2020

Feb 11, 2021

SELL
$72.61 - $90.2 $642,888 - $798,630
-8,854 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$71.87 - $131.03 $836,782 - $1.53 Million
-11,643 Reduced 56.8%
8,854 $674,000
Q2 2020

Aug 07, 2020

BUY
$79.55 - $124.22 $246,764 - $385,330
3,102 Added 17.83%
20,497 $2.53 Million
Q1 2020

May 08, 2020

BUY
$71.37 - $96.85 $1.24 Million - $1.68 Million
17,395 New
17,395 $1.47 Million
Q3 2019

Nov 08, 2019

SELL
$67.4 - $85.11 $1.49 Million - $1.88 Million
-22,049 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$80.35 - $93.9 $1.77 Million - $2.07 Million
22,049 New
22,049 $1.89 Million
Q2 2018

Aug 07, 2018

SELL
$76.01 - $99.03 $1.02 Million - $1.33 Million
-13,397 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$77.67 - $92.63 $1.04 Million - $1.24 Million
13,397 New
13,397 $1.09 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.